Rock Springs Capital Management’s NovoCure NVCR Stock Holding History
Bought
Maintained
Sold
Other funds holding NVCR
DTC
Rock Springs Capital Management's NVCR Position: Q3 2023 in Review
Rock Springs Capital Management sold out of NovoCure (NVCR) in Q3 2023, closing a stake of 125,000 shares — an estimated $5.19M sold.
Rock Springs Capital Management first reported a position in NVCR in Q4 2015 and held it in 26 quarters. The position peaked at $38.8M in Q2 2021. 226 funds tracked by Wall St. Rank hold NVCR as of Q3 2023.
- Rock Springs Capital Management reported no remaining NovoCure position as of Q3 2023 after selling out during the quarter.
- Rock Springs Capital Management sold 125,000 NovoCure shares in Q3 2023, an estimated $5.19M.
- Rock Springs Capital Management first reported a position in NovoCure in Q4 2015 and held it in 26 quarters.
- Rock Springs Capital Management's NovoCure position peaked at $38.8M in Q2 2021.
- 226 funds tracked by Wall St. Rank held NovoCure as of Q3 2023.
Based on Rock Springs Capital Management's 13F filing for Q3 2023, filed 14 Nov 2023.